SG11201908183YA - Skin barrier composition - Google Patents

Skin barrier composition

Info

Publication number
SG11201908183YA
SG11201908183YA SG11201908183YA SG11201908183YA SG 11201908183Y A SG11201908183Y A SG 11201908183YA SG 11201908183Y A SG11201908183Y A SG 11201908183YA SG 11201908183Y A SG11201908183Y A SG 11201908183YA
Authority
SG
Singapore
Prior art keywords
international
skin
floor
pct
composition
Prior art date
Application number
Other languages
English (en)
Inventor
Kevin Hammond
Adrian Davis
Original Assignee
Hyphens Pharma Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyphens Pharma Pte Ltd filed Critical Hyphens Pharma Pte Ltd
Publication of SG11201908183YA publication Critical patent/SG11201908183YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201908183Y 2017-05-10 2018-05-10 Skin barrier composition SG11201908183YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1707489.9A GB2562270B (en) 2017-05-10 2017-05-10 Skin barrier composition
PCT/GB2018/051262 WO2018206962A1 (en) 2017-05-10 2018-05-10 Skin barrier composition

Publications (1)

Publication Number Publication Date
SG11201908183YA true SG11201908183YA (en) 2019-10-30

Family

ID=59065602

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201908183Y SG11201908183YA (en) 2017-05-10 2018-05-10 Skin barrier composition

Country Status (11)

Country Link
US (2) US11173172B2 (ja)
EP (1) EP3621653A1 (ja)
JP (1) JP7228531B2 (ja)
KR (1) KR102646319B1 (ja)
CN (1) CN110621346B (ja)
AU (1) AU2018267267B2 (ja)
GB (1) GB2562270B (ja)
MY (1) MY189248A (ja)
PH (1) PH12019502062A1 (ja)
SG (1) SG11201908183YA (ja)
WO (1) WO2018206962A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3641725A1 (en) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition and method for improving the appearance of skin
EP3817717A1 (en) 2018-07-03 2021-05-12 The Procter & Gamble Company Method of treating a skin condition
JP2023528616A (ja) 2020-06-01 2023-07-05 ザ プロクター アンド ギャンブル カンパニー ビタミンb3化合物の皮膚への浸透を改善する方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
GB2596286B (en) * 2020-06-20 2023-01-25 Francis Davis Adrian Adherence to topical therapy
US20220192961A1 (en) * 2020-12-17 2022-06-23 L'oreal Hydroglycolic cosmetic composition with a high active content
GB2616294A (en) * 2022-03-03 2023-09-06 Hyphens Pharma Pte Ltd Composition for use

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954487A (en) * 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US5385938B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
DE69328682T2 (de) * 1992-06-19 2000-12-28 Univ California Lipide zur epidermalen Befeuchtung und zur Wiederherstellung der Barrierefunktion
DK0752843T3 (da) * 1994-03-29 2001-03-19 Procter & Gamble Sammensætninger til kunstig solbrændthed, som har forbedret farveudvikling
US5618850A (en) * 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
DE19719856A1 (de) * 1997-05-12 1998-11-19 Henkel Kgaa Hautpflegemittel
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
JP3713406B2 (ja) 1999-07-16 2005-11-09 株式会社資生堂 皮膚外用ゲル製剤
US20020119174A1 (en) * 2000-07-26 2002-08-29 Gardlik John Michael Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates
US20020035070A1 (en) * 2000-07-26 2002-03-21 The Procter & Gamble Company Method of regulating hair growth using metal complexes of oxidized carbohydrates
EP1324737A2 (en) * 2000-10-10 2003-07-09 The Procter & Gamble Company Packaged scalp cosmetic compositions
EP1670433B1 (en) 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
CA2595023A1 (en) 2005-01-19 2006-07-27 Children's Hospital Medical Center Simulated vernix compositions for skin cleansing and other applications
WO2006081071A1 (en) 2005-01-26 2006-08-03 The Procter & Gamble Company Low ph skin care compositions containing dehydroacetic acid
GB0617191D0 (en) 2006-08-31 2006-10-11 York Pharma Plc Improvements in pharmaceutical compositions
JP5578869B2 (ja) 2010-01-27 2014-08-27 ユニチカ株式会社 角質層ターンオーバー促進剤
KR101773095B1 (ko) 2010-11-30 2017-08-31 (주)아모레퍼시픽 저점도의 비분리형 자외선차단제 조성물
JP2013060393A (ja) 2011-09-13 2013-04-04 Nitto Denko Corp 経皮吸収促進用組成物および貼付製剤
US9636376B2 (en) * 2012-09-11 2017-05-02 Innopharma, Inc. Stable compositions of peptide epoxy ketones
JP6151935B2 (ja) 2013-03-11 2017-06-21 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
US20150024074A1 (en) * 2013-07-22 2015-01-22 Johnson & Johnson Consumer Companies Inc. Methods for treating skin barrier and reducing acne
JP2014114291A (ja) * 2013-12-13 2014-06-26 Showa Denko Kk 化粧料または皮膚外用剤
KR20160026042A (ko) 2014-08-29 2016-03-09 (주)아모레퍼시픽 락토비온산을 함유하는 항스트레스용 또는 항상성 유지용 조성물
CN105434213A (zh) * 2015-08-04 2016-03-30 马南行 一种舒缓皮肤的美容组合物及其制备方法

Also Published As

Publication number Publication date
KR102646319B1 (ko) 2024-03-11
KR20190142324A (ko) 2019-12-26
US11890294B2 (en) 2024-02-06
US11173172B2 (en) 2021-11-16
EP3621653A1 (en) 2020-03-18
AU2018267267B2 (en) 2023-09-07
CN110621346A (zh) 2019-12-27
US20200222438A1 (en) 2020-07-16
JP2020519649A (ja) 2020-07-02
CN110621346B (zh) 2024-04-12
GB201707489D0 (en) 2017-06-21
WO2018206962A1 (en) 2018-11-15
GB2562270B (en) 2020-07-01
GB2562270A (en) 2018-11-14
PH12019502062A1 (en) 2020-07-06
US20220031721A1 (en) 2022-02-03
AU2018267267A1 (en) 2019-10-10
JP7228531B2 (ja) 2023-02-24
MY189248A (en) 2022-01-31

Similar Documents

Publication Publication Date Title
SG11201908183YA (en) Skin barrier composition
SG11201803920TA (en) Compounds and compositions useful for treating disorders related to ntrk
SG11201906891RA (en) Methods for the administration of certain vmat2 inhibitors
SG11201903938XA (en) Acylated glp-1/glp-2 dual agonists
SG11201811149TA (en) METABOLIC DRUG LOADING OF EVs
SG11201811150WA (en) Ev-mediated delivery of binding protein-small molecule conjugates
SG11201811148SA (en) Cell penetrating peptide (cpp)-mediated ev loading
SG11201808682XA (en) Silicone atoms containing ivacaftor analogues
SG11201900163PA (en) Macrocycle kinase inhibitors
SG11201806583XA (en) Compositions containing tucaresol or its analogs
SG11201407397WA (en) Formulations and methods for vaginal delivery of antiprogestins
SG11201407536UA (en) Topical pharmaceutical compositions comprising terbinafine and urea
SG11201901070YA (en) Formulations for oral administration of active agents
SG11201806544XA (en) Compounds and methods of treating rna-mediated diseases
SG11201811351WA (en) Compositions and methods for forming stable, liquid metal oxide/hydroxide formulations
SG11201909735YA (en) Therapeutic compounds and compositions, and methods of use thereof
SG11201809976PA (en) Protection of plant extracts and compounds from degradation
SG11201901048VA (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
SG11201908114UA (en) Pyrimidopyrimidinones useful as wee-1 kinase inhibitors
SG11201910206QA (en) Methods and compositions for treating inflammatory gastrointestinal disorders
SG11201805149XA (en) Compositions comprising 15-hepe and methods of using the same
SG11201808650QA (en) Methods of treating ocular conditions
SG11201909478UA (en) Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
SG11201810403VA (en) Drug-delivery nanoparticles and treatments for drug-resistant cancer
SG11201909016TA (en) Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety